2015-05-13 19:01:17 UTC

Dr. Boland Awarded 2015 Beaumont Prize

May 18, 2015

C. Richard Boland, MD, AGAF, received the William Beaumont Prize during DDW® 2015.

AGA presented C. Richard Boland, MD, AGAF, of Baylor University Medical Center in Dallas, TX, with its William Beaumont Prize, which recognizes an individual who has made a unique, outstanding contribution of major importance to the field of gastroenterology. Dr. Boland, who received the award at Digestive Disease Week® (DDW) 2015, has made seminal contributions to our understanding of the major molecular mechanisms of colorectal cancer (CRC) and other neoplastic lesions of the gut, particularly in advancing our understanding of Lynch Syndrome and the importance of the DNA mismatch repair system in colonic carcinogenesis.These contributions, along with his mentoring and educational talents, and his decades of service to AGA, make Dr. Boland most deserving of this award.

Dr. Boland, who currently serves as the Chief of Gastroenterology at Baylor University Medical Center— a position he has held for more than 12 years — is internationally known for his role in the description and research of Lynch syndrome. Dr. Boland began his work on CRC as a medical student, when he independently discovered hereditary non-polyposis CRC in 1972 in pursuit of his MD thesis, and he has continued to work on this topic for more than 40 years. His laboratory was among the first to develop methods to characterize DNA alterations from microdissections of paraffin embedded tissue. Among countless other contributions, his group also developed the first (and still extensively used) in vitro model for the study of the DNA mismatch repair genes responsible for Lynch syndrome, demonstrating the role of those genes in regulating the cell cycle. These cell lines have been used by perhaps 100 laboratories around the world.

Dr. Boland has published more than 360 papers focusing on CRC and hereditary CRC. Since 1979, he has been continuously funded by the NIH and the Veteran’s Administration for his research. Dr. Boland has been a thought leader in this field, participating in almost every major guideline development effort and has written many reviews highlighting the importance of hereditary cancer, particularly Lynch syndrome. He also exhibits excellent mentorship, training more than 75 mentees who have all gone into gastroenterology and related fields.

Dr. Boland has been a member of the AGA since 1978 serving in many high-level capacities, such as Chair of the GI Oncology Section, Chair of the AGA Research Committee, Associate Editor of Gastroenterology, and culminating as president of the AGA from 2011 to 2012. He also received the GI Oncology Section Distinguished Mentor Award in May of 2011.

After receiving his medical degree from Yale University, New Haven, CT, in 1973, and spending two years in the Indian Health Service as a general medical officer, Dr. Boland completed his residency at the U.S. Public Health Service Hospital, San Francisco, CA. From 1978 to 1981, Dr. Boland was a GI fellow at the University of California, San Francisco (UCSF) School of Medicine, where he was appointed assistant professor in 1981. From 1984 to 1995, Dr. Boland served as the chief of the GI section at the Ann Arbor VA and faculty member at the University of Michigan School of Medicine, Ann Arbor. In 1995, he served as professor of medicine and GI division chief at the University of California, San Diego. Since 2003, Dr. Boland run the GI Cancer Research Laboratory at the Baylor University Medical Center at Dallas, and has adjunct appointments at the University of Texas Southwestern, Texas A&M College of Medicine, and Baylor University.

More on Colorectal Cancer

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

Advocate CMS, close the colonoscopy loophole

March 8, 2018

AGA urges CMS to address the cost sharing problem that arises when screening colonoscopies become diagnostic for Medicare patients.